StrokeNet Thrombectomy Endovascular Platform

Study overview

STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Collaborators and Investigators

Medical University of South Carolina,

Jordan J Elm, PhD, PRINCIPAL_INVESTIGATOR, Medical University of South Carolina

Eva A Mistry, MBBS, MSCI, PRINCIPAL_INVESTIGATOR, University of Cincinnati

Pooja Khatri, MD, PRINCIPAL_INVESTIGATOR, University of Cincinnati

Colin P Derdeyn, MD, PRINCIPAL_INVESTIGATOR, University of Virginia

Jeffery L Saver, MD, PRINCIPAL_INVESTIGATOR, University of California, Los Angeles

Tudor G Jovin, MD, PRINCIPAL_INVESTIGATOR, The Cooper Health System

Raul G Nogueira, MD, FAHA, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

David Fiorella, MD, PhD, PRINCIPAL_INVESTIGATOR, Stony Brook University

Adnan Siddiqui, MD, PhD, PRINCIPAL_INVESTIGATOR, University at Buffalo

J Mocco, MD, MS, PRINCIPAL_INVESTIGATOR, MOUNT SINAI HOSPITAL

Study Record Dates

2030-01-31